Search results (219)
« Back to NewsWellcome Career Development Award For Agne Antanaviciute
2 April 2025
Dr Agne Antanaviciute has won a Wellcome Career Development Award for her research investigating early-life immunity.
New study reveals details of key immune mechanism
25 March 2025
An international collaboration, initiated by the Jackson Group at the MRC WIMM, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.
Ancient genomic linkage regulates red blood cell development
24 March 2025
A collaboration between the Drakesmith and Higgs Groups at the MRC WIMM has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.
Wellcome Career Development Award For Sumana Sharma
14 March 2025
Dr Sumana Sharma has won a Wellcome Career Development Award for her research investigating receptors in T cells.
Adam Wilkinson wins 2025 ISEH Janet Rowley Award
13 March 2025
Associate Professor Adam Wilkinson has received the 2025 Janet Rowley Award from the International Society for Experimental Haematology for his outstanding contributions in the field of hematopoietic stem cell biology.
International Women's Day 2025
7 March 2025
For International Women's Day on 8th March 2025, women from the MRC WIMM reflect on why this day is so important, the barriers and biases women can face in their careers, and which women have inspired them.
Rare Disease Day 2025
27 February 2025
For Rare Disease Day on the 28th February, we spoke to three of our researchers about their work, discussing both the challenges and importance of researching and treating rare diseases.
Therapy Acceleration Lab granted UKAS accreditation
27 February 2025
The Therapy Acceleration Lab (TAL) at the MRC WIMM was recently accredited by the United Kingdom Accreditation Service (UKAS) to the ISO 17025:2017 Standard as a testing laboratory, No. 28562.
Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research
21 February 2025
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
MRC WIMM researchers win 2024 RDM Graduate Prize
28 January 2025
Congratulations to Charlotte Brierley and Patrick Pflughaupt, who were both awarded the 2024 RDM Graduate Prize after completing their PhDs at the MRC WIMM.
Funding awarded for new theatre-based community engagement project
23 January 2025
Alison Kay and Anne Goriely, together with Minna Jeffery (St. Anne’s College) and Lisa Hinton (Nuffield Dept. of Primary Care Health Sciences), have won an award from the University of Oxford’s PCER Fund for a project called “Making it personal”, which will use theatre to explore public perception of a new form of genetic testing.
MRC WIMM Festive Decorating Competition 2024
20 December 2024
Teams across the MRC WIMM decorated their labs and offices with tinsel, handmade decorations and repurposed lab materials, filling the Institute with festive cheer.
Davis Group receives Wellcome Discovery Award
2 December 2024
Professor Simon Davis and Dr Mafalda Santos have won a 5-year award from the global charitable foundation Wellcome to fund a project titled “Small contacts, big decisions – early signal processing by T cells”. This has been awarded jointly with Professor Anna Lippert of the University of Würzburg.
35 Years of the MRC WIMM
23 October 2024
In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.
New biomarker and therapeutic target identified for blood cancers
10 October 2024
Research from the MRC Molecular Haematology Unit has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms (a type of blood cancer).